The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
The aim of the present study is to compare patients' satisfaction with pain medication during the first 7 first postoperative days following elective hallux valgus surgery in general anaesthesia between etoricoxib and diclofenac in a prospective randomised double-blind study design.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
120 mg once daily for the 1st 6 postoperative days
50 mg oral 3 times daily the 1st 6 postoperative days
Patients Global Evaluation of Study Medication
Patients self-assessment of global satisfaction with pain medication
Time frame: postoperative day 1-6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.